“Dapagliflozin and Urinary Tract Infection Risk in Type 2 Diabetes: A Comprehensive Critical Review of Mechanistic, Randomized, and Real-World Evidence”. Tropical Journal of Pharmaceutical and Life Sciences, vol. 13, no. 5, Oct. 2026, pp. 53-68, https://doi.org/10.61280/9h681f91.